BMS at ECTRIMS 2021
Intended for U.S. scientific audiences only.
The 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) is an important opportunity to reinforce our commitment to help, with the goal of preserving physical and cognitive functions in people living with multiple sclerosis (MS) through scientific exchange on research and breakthroughs. We look forward to showcasing new research and sharing progress with the MS community.
Our Data at ECTRIMS 2021
Read more about our key data being presented at the meeting.
Our Science & Commitment
We are pursuing pathbreaking science and innovative solutions to potentially improve outcomes in MS. Read how our team is working to delay progression and prevent disability for individuals diagnosed with MS.
Hear from Cathy Trzaskawka (Traz), executive director, Bristol Myers Squibb Patient Advocacy, and Richard Nieman, senior vice president, Worldwide Medical, Immunology & Fibrosis, to learn how Bristol Myers Squibb's work in MS goes beyond the medicine, and how the company supports the entire community.
Learn more about our research in MS through the resources below.